GLP-1 and GLP-2 Orchestrate Intestine Integrity, Gut Microbiota, and Immune System Crosstalk

被引:48
作者
Abdalqadir, Nyan [1 ,2 ,3 ]
Adeli, Khosrow [1 ,2 ,4 ,5 ]
机构
[1] Hosp Sick Children, Res Inst, Mol Med, Toronto, ON M5G 1H3, Canada
[2] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada
[3] Univ Sulaimani, Coll Sci, Dept Biol, Sulaymaniyah 46001, Iraq
[4] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada
[5] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada
关键词
glucagon-like peptide 1 (GLP-1); glucagon-like peptide 2 (GLP-2); gut microbiota; intestinal barrier integrity; inflammation; gut immunity; metabolic syndrome; GLUCAGON-LIKE PEPTIDE-1; CHAIN FATTY-ACIDS; PROTEIN-COUPLED RECEPTOR; GERM-FREE MICE; CHYLOMICRON PRODUCTION; INSULIN-SECRETION; OXIDATIVE STRESS; FOOD-INTAKE; L CELLS; LIPOPROTEIN PRODUCTION;
D O I
10.3390/microorganisms10102061
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The intestine represents the body's largest interface between internal organs and external environments except for its nutrient and fluid absorption functions. It has the ability to sense numerous endogenous and exogenous signals from both apical and basolateral surfaces and respond through endocrine and neuronal signaling to maintain metabolic homeostasis and energy expenditure. The intestine also harbours the largest population of microbes that interact with the host to maintain human health and diseases. Furthermore, the gut is known as the largest endocrine gland, secreting over 100 peptides and other molecules that act as signaling molecules to regulate human nutrition and physiology. Among these gut-derived hormones, glucagon-like peptide 1 (GLP-1) and -2 have received the most attention due to their critical role in intestinal function and food absorption as well as their application as key drug targets. In this review, we highlight the current state of the literature that has brought into light the importance of GLP-1 and GLP-2 in orchestrating intestine-microbiota-immune system crosstalk to maintain intestinal barrier integrity, inflammation, and metabolic homeostasis.
引用
收藏
页数:20
相关论文
共 210 条
  • [1] The inhibitory effects of peripheral administration of peptide YY3-36 and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway
    Abbott, CR
    Monteiro, M
    Small, CJ
    Sajedi, A
    Smith, KL
    Parkinson, JRC
    Ghatei, MA
    Bloom, SR
    [J]. BRAIN RESEARCH, 2005, 1044 (01) : 127 - 131
  • [2] Glucagon-like peptide-1 exerts anti-inflammatory effects on mouse colon smooth muscle cells through the cyclic adenosine monophosphate/nuclear factor-κB pathway in vitro
    Al-Dwairi, Ahmed
    Alqudah, Tamara E.
    Al-Shboul, Othman
    Alqudah, Mohammad
    Mustafa, Ayman G.
    Alfaqih, Mahmoud A.
    [J]. JOURNAL OF INFLAMMATION RESEARCH, 2018, 11 : 95 - 109
  • [3] GLP-1 nanomedicine alleviates gut inflammation
    Anbazhagan, Arivarasu N.
    Thaqi, Mentor
    Priyamvada, Shubha
    Jayawardena, Dulari
    Kumar, Anoop
    Gujral, Tarunmeet
    Chatterjee, Ishita
    Mugarza, Edurne
    Saksena, Seema
    Onyuksel, Hayat
    Dudeja, Pradeep K.
    [J]. NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2017, 13 (02) : 659 - 665
  • [4] Lipopolysaccharides-Mediated Increase in Glucose-Stimulated Insulin Secretion: Involvement of the GLP-1 Pathway
    Anh Thoai Nguyen
    Mandard, Stephane
    Dray, Cedric
    Deckert, Valerie
    Valet, Philippe
    Besnard, Philippe
    Drucker, Daniel J.
    Lagrost, Laurent
    Grober, Jacques
    [J]. DIABETES, 2014, 63 (02) : 471 - 482
  • [5] Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4
    Arakawa, Masayuki
    Mita, Tomoya
    Azuma, Kosuke
    Ebato, Chie
    Goto, Hiromasa
    Nomiyama, Takashi
    Fujitani, Yoshio
    Hirose, Takahisa
    Kawamori, Ryuzo
    Watada, Hirotaka
    [J]. DIABETES, 2010, 59 (04) : 1030 - 1037
  • [6] Short-Chain Fatty Acids Regulate Secretion of IL-8 from Human Intestinal Epithelial Cell Lines in vitro
    Asarat, M.
    Vasiljevic, T.
    Apostolopoulos, V.
    Donkor, O.
    [J]. IMMUNOLOGICAL INVESTIGATIONS, 2015, 44 (07) : 678 - 693
  • [7] The pivotal relation between glucagon-like peptides, NFκB and inflammatory bowel disease
    Azmy Nabeh, Omnia
    Ishak Attallah, Magdy
    El-Sayed El-Gawhary, Nawal
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2020, 47 (10) : 1641 - 1648
  • [8] Biology of incretins: GLP-1 and GIP
    Baggio, Laurie L.
    Drucker, Daniel J.
    [J]. GASTROENTEROLOGY, 2007, 132 (06) : 2131 - 2157
  • [9] GLP-1 Induces Barrier Protective Expression in Brunner's Glands and Regulates Colonic Inflammation
    Bang-Berthelsen, Claus H.
    Holm, Thomas L.
    Pyke, Charles
    Simonsen, Lotte
    Sokilde, Rolf
    Pociot, Flemming
    Heller, R. Scott
    Folkersen, Lasse
    Kvist, Peter H.
    Jackerott, Malene
    Fleckner, Jan
    Vilien, Mogens
    Knudsen, Lotte B.
    Heding, Anders
    Frederiksen, Klaus S.
    [J]. INFLAMMATORY BOWEL DISEASES, 2016, 22 (09) : 2078 - 2097
  • [10] The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation
    Bansal, Tarun
    Alaniz, Robert C.
    Wood, Thomas K.
    Jayaraman, Arul
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (01) : 228 - 233